Drugs for Toxoplasmosis Market, Global Outlook and Forecast 2022-2028

February 2022 | 77 pages | ID: D17ED263BD3FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Drugs for Toxoplasmosis in global, including the following market information:

Global Drugs for Toxoplasmosis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Drugs for Toxoplasmosis Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Drugs for Toxoplasmosis companies in 2021 (%)

The global Drugs for Toxoplasmosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drugs for Toxoplasmosis include Turing Pharmaceutical, Snowdon, Guangzhou Baiyunshan Pharmaceutical Co., Ltd., Taj Pharmaceuticals Limited and Glaxo Smithkline Pharmaceuticals Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Toxoplasmosis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs for Toxoplasmosis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Drugs for Toxoplasmosis Market Segment Percentages, by Type, 2021 (%)

• Injection
• Tablet
• Others

Global Drugs for Toxoplasmosis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Drugs for Toxoplasmosis Market Segment Percentages, by Application, 2021 (%)

• Chronic Toxoplasmosis Treatment
• Acute Toxoplasmosis Treatment
• Other

Global Drugs for Toxoplasmosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Drugs for Toxoplasmosis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drugs for Toxoplasmosis revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Drugs for Toxoplasmosis revenues share in global market, 2021 (%)

Key companies Drugs for Toxoplasmosis sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Drugs for Toxoplasmosis sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Turing Pharmaceutical
• Snowdon
• Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
• Taj Pharmaceuticals Limited
• Glaxo Smithkline Pharmaceuticals Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drugs for Toxoplasmosis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drugs for Toxoplasmosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUGS FOR TOXOPLASMOSIS OVERALL MARKET SIZE

2.1 Global Drugs for Toxoplasmosis Market Size: 2021 VS 2028
2.2 Global Drugs for Toxoplasmosis Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Drugs for Toxoplasmosis Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Drugs for Toxoplasmosis Players in Global Market
3.2 Top Global Drugs for Toxoplasmosis Companies Ranked by Revenue
3.3 Global Drugs for Toxoplasmosis Revenue by Companies
3.4 Global Drugs for Toxoplasmosis Sales by Companies
3.5 Global Drugs for Toxoplasmosis Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Drugs for Toxoplasmosis Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Drugs for Toxoplasmosis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Toxoplasmosis Players in Global Market
  3.8.1 List of Global Tier 1 Drugs for Toxoplasmosis Companies
  3.8.2 List of Global Tier 2 and Tier 3 Drugs for Toxoplasmosis Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Drugs for Toxoplasmosis Market Size Markets, 2021 & 2028
  4.1.2 Injection
  4.1.3 Tablet
  4.1.4 Others
4.2 By Type - Global Drugs for Toxoplasmosis Revenue & Forecasts
  4.2.1 By Type - Global Drugs for Toxoplasmosis Revenue, 2017-2022
  4.2.2 By Type - Global Drugs for Toxoplasmosis Revenue, 2023-2028
  4.2.3 By Type - Global Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
4.3 By Type - Global Drugs for Toxoplasmosis Sales & Forecasts
  4.3.1 By Type - Global Drugs for Toxoplasmosis Sales, 2017-2022
  4.3.2 By Type - Global Drugs for Toxoplasmosis Sales, 2023-2028
  4.3.3 By Type - Global Drugs for Toxoplasmosis Sales Market Share, 2017-2028
4.4 By Type - Global Drugs for Toxoplasmosis Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drugs for Toxoplasmosis Market Size, 2021 & 2028
  5.1.2 Chronic Toxoplasmosis Treatment
  5.1.3 Acute Toxoplasmosis Treatment
  5.1.4 Other
5.2 By Application - Global Drugs for Toxoplasmosis Revenue & Forecasts
  5.2.1 By Application - Global Drugs for Toxoplasmosis Revenue, 2017-2022
  5.2.2 By Application - Global Drugs for Toxoplasmosis Revenue, 2023-2028
  5.2.3 By Application - Global Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
5.3 By Application - Global Drugs for Toxoplasmosis Sales & Forecasts
  5.3.1 By Application - Global Drugs for Toxoplasmosis Sales, 2017-2022
  5.3.2 By Application - Global Drugs for Toxoplasmosis Sales, 2023-2028
  5.3.3 By Application - Global Drugs for Toxoplasmosis Sales Market Share, 2017-2028
5.4 By Application - Global Drugs for Toxoplasmosis Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Drugs for Toxoplasmosis Market Size, 2021 & 2028
6.2 By Region - Global Drugs for Toxoplasmosis Revenue & Forecasts
  6.2.1 By Region - Global Drugs for Toxoplasmosis Revenue, 2017-2022
  6.2.2 By Region - Global Drugs for Toxoplasmosis Revenue, 2023-2028
  6.2.3 By Region - Global Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
6.3 By Region - Global Drugs for Toxoplasmosis Sales & Forecasts
  6.3.1 By Region - Global Drugs for Toxoplasmosis Sales, 2017-2022
  6.3.2 By Region - Global Drugs for Toxoplasmosis Sales, 2023-2028
  6.3.3 By Region - Global Drugs for Toxoplasmosis Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Drugs for Toxoplasmosis Revenue, 2017-2028
  6.4.2 By Country - North America Drugs for Toxoplasmosis Sales, 2017-2028
  6.4.3 US Drugs for Toxoplasmosis Market Size, 2017-2028
  6.4.4 Canada Drugs for Toxoplasmosis Market Size, 2017-2028
  6.4.5 Mexico Drugs for Toxoplasmosis Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Drugs for Toxoplasmosis Revenue, 2017-2028
  6.5.2 By Country - Europe Drugs for Toxoplasmosis Sales, 2017-2028
  6.5.3 Germany Drugs for Toxoplasmosis Market Size, 2017-2028
  6.5.4 France Drugs for Toxoplasmosis Market Size, 2017-2028
  6.5.5 U.K. Drugs for Toxoplasmosis Market Size, 2017-2028
  6.5.6 Italy Drugs for Toxoplasmosis Market Size, 2017-2028
  6.5.7 Russia Drugs for Toxoplasmosis Market Size, 2017-2028
  6.5.8 Nordic Countries Drugs for Toxoplasmosis Market Size, 2017-2028
  6.5.9 Benelux Drugs for Toxoplasmosis Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Drugs for Toxoplasmosis Revenue, 2017-2028
  6.6.2 By Region - Asia Drugs for Toxoplasmosis Sales, 2017-2028
  6.6.3 China Drugs for Toxoplasmosis Market Size, 2017-2028
  6.6.4 Japan Drugs for Toxoplasmosis Market Size, 2017-2028
  6.6.5 South Korea Drugs for Toxoplasmosis Market Size, 2017-2028
  6.6.6 Southeast Asia Drugs for Toxoplasmosis Market Size, 2017-2028
  6.6.7 India Drugs for Toxoplasmosis Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Drugs for Toxoplasmosis Revenue, 2017-2028
  6.7.2 By Country - South America Drugs for Toxoplasmosis Sales, 2017-2028
  6.7.3 Brazil Drugs for Toxoplasmosis Market Size, 2017-2028
  6.7.4 Argentina Drugs for Toxoplasmosis Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Drugs for Toxoplasmosis Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Drugs for Toxoplasmosis Sales, 2017-2028
  6.8.3 Turkey Drugs for Toxoplasmosis Market Size, 2017-2028
  6.8.4 Israel Drugs for Toxoplasmosis Market Size, 2017-2028
  6.8.5 Saudi Arabia Drugs for Toxoplasmosis Market Size, 2017-2028
  6.8.6 UAE Drugs for Toxoplasmosis Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Turing Pharmaceutical
  7.1.1 Turing Pharmaceutical Corporate Summary
  7.1.2 Turing Pharmaceutical Business Overview
  7.1.3 Turing Pharmaceutical Drugs for Toxoplasmosis Major Product Offerings
  7.1.4 Turing Pharmaceutical Drugs for Toxoplasmosis Sales and Revenue in Global (2017-2022)
  7.1.5 Turing Pharmaceutical Key News
7.2 Snowdon
  7.2.1 Snowdon Corporate Summary
  7.2.2 Snowdon Business Overview
  7.2.3 Snowdon Drugs for Toxoplasmosis Major Product Offerings
  7.2.4 Snowdon Drugs for Toxoplasmosis Sales and Revenue in Global (2017-2022)
  7.2.5 Snowdon Key News
7.3 Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  7.3.1 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Corporate Summary
  7.3.2 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Business Overview
  7.3.3 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Drugs for Toxoplasmosis Major Product Offerings
  7.3.4 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Drugs for Toxoplasmosis Sales and Revenue in Global (2017-2022)
  7.3.5 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Key News
7.4 Taj Pharmaceuticals Limited
  7.4.1 Taj Pharmaceuticals Limited Corporate Summary
  7.4.2 Taj Pharmaceuticals Limited Business Overview
  7.4.3 Taj Pharmaceuticals Limited Drugs for Toxoplasmosis Major Product Offerings
  7.4.4 Taj Pharmaceuticals Limited Drugs for Toxoplasmosis Sales and Revenue in Global (2017-2022)
  7.4.5 Taj Pharmaceuticals Limited Key News
7.5 Glaxo Smithkline Pharmaceuticals Ltd.
  7.5.1 Glaxo Smithkline Pharmaceuticals Ltd. Corporate Summary
  7.5.2 Glaxo Smithkline Pharmaceuticals Ltd. Business Overview
  7.5.3 Glaxo Smithkline Pharmaceuticals Ltd. Drugs for Toxoplasmosis Major Product Offerings
  7.5.4 Glaxo Smithkline Pharmaceuticals Ltd. Drugs for Toxoplasmosis Sales and Revenue in Global (2017-2022)
  7.5.5 Glaxo Smithkline Pharmaceuticals Ltd. Key News

8 GLOBAL DRUGS FOR TOXOPLASMOSIS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Drugs for Toxoplasmosis Production Capacity, 2017-2028
8.2 Drugs for Toxoplasmosis Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Toxoplasmosis Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DRUGS FOR TOXOPLASMOSIS SUPPLY CHAIN ANALYSIS

10.1 Drugs for Toxoplasmosis Industry Value Chain
10.2 Drugs for Toxoplasmosis Upstream Market
10.3 Drugs for Toxoplasmosis Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Drugs for Toxoplasmosis Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Drugs for Toxoplasmosis in Global Market
Table 2. Top Drugs for Toxoplasmosis Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Drugs for Toxoplasmosis Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Drugs for Toxoplasmosis Revenue Share by Companies, 2017-2022
Table 5. Global Drugs for Toxoplasmosis Sales by Companies, (K MT), 2017-2022
Table 6. Global Drugs for Toxoplasmosis Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Drugs for Toxoplasmosis Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Drugs for Toxoplasmosis Product Type
Table 9. List of Global Tier 1 Drugs for Toxoplasmosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Toxoplasmosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Drugs for Toxoplasmosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Drugs for Toxoplasmosis Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Drugs for Toxoplasmosis Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Drugs for Toxoplasmosis Sales (K MT), 2017-2022
Table 15. By Type - Global Drugs for Toxoplasmosis Sales (K MT), 2023-2028
Table 16. By Application – Global Drugs for Toxoplasmosis Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Drugs for Toxoplasmosis Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Drugs for Toxoplasmosis Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Drugs for Toxoplasmosis Sales (K MT), 2017-2022
Table 20. By Application - Global Drugs for Toxoplasmosis Sales (K MT), 2023-2028
Table 21. By Region – Global Drugs for Toxoplasmosis Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Drugs for Toxoplasmosis Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Drugs for Toxoplasmosis Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Drugs for Toxoplasmosis Sales (K MT), 2017-2022
Table 25. By Region - Global Drugs for Toxoplasmosis Sales (K MT), 2023-2028
Table 26. By Country - North America Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Drugs for Toxoplasmosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Drugs for Toxoplasmosis Sales, (K MT), 2017-2022
Table 29. By Country - North America Drugs for Toxoplasmosis Sales, (K MT), 2023-2028
Table 30. By Country - Europe Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Drugs for Toxoplasmosis Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Drugs for Toxoplasmosis Sales, (K MT), 2017-2022
Table 33. By Country - Europe Drugs for Toxoplasmosis Sales, (K MT), 2023-2028
Table 34. By Region - Asia Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Drugs for Toxoplasmosis Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Drugs for Toxoplasmosis Sales, (K MT), 2017-2022
Table 37. By Region - Asia Drugs for Toxoplasmosis Sales, (K MT), 2023-2028
Table 38. By Country - South America Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Drugs for Toxoplasmosis Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Drugs for Toxoplasmosis Sales, (K MT), 2017-2022
Table 41. By Country - South America Drugs for Toxoplasmosis Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Drugs for Toxoplasmosis Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Drugs for Toxoplasmosis Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Drugs for Toxoplasmosis Sales, (K MT), 2023-2028
Table 46. Turing Pharmaceutical Corporate Summary
Table 47. Turing Pharmaceutical Drugs for Toxoplasmosis Product Offerings
Table 48. Turing Pharmaceutical Drugs for Toxoplasmosis Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Snowdon Corporate Summary
Table 50. Snowdon Drugs for Toxoplasmosis Product Offerings
Table 51. Snowdon Drugs for Toxoplasmosis Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Corporate Summary
Table 53. Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Drugs for Toxoplasmosis Product Offerings
Table 54. Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Drugs for Toxoplasmosis Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Taj Pharmaceuticals Limited Corporate Summary
Table 56. Taj Pharmaceuticals Limited Drugs for Toxoplasmosis Product Offerings
Table 57. Taj Pharmaceuticals Limited Drugs for Toxoplasmosis Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Glaxo Smithkline Pharmaceuticals Ltd. Corporate Summary
Table 59. Glaxo Smithkline Pharmaceuticals Ltd. Drugs for Toxoplasmosis Product Offerings
Table 60. Glaxo Smithkline Pharmaceuticals Ltd. Drugs for Toxoplasmosis Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Drugs for Toxoplasmosis Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 62. Global Drugs for Toxoplasmosis Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Drugs for Toxoplasmosis Production by Region, 2017-2022 (K MT)
Table 64. Global Drugs for Toxoplasmosis Production by Region, 2023-2028 (K MT)
Table 65. Drugs for Toxoplasmosis Market Opportunities & Trends in Global Market
Table 66. Drugs for Toxoplasmosis Market Drivers in Global Market
Table 67. Drugs for Toxoplasmosis Market Restraints in Global Market
Table 68. Drugs for Toxoplasmosis Raw Materials
Table 69. Drugs for Toxoplasmosis Raw Materials Suppliers in Global Market
Table 70. Typical Drugs for Toxoplasmosis Downstream
Table 71. Drugs for Toxoplasmosis Downstream Clients in Global Market
Table 72. Drugs for Toxoplasmosis Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Drugs for Toxoplasmosis Segment by Type
Figure 2. Drugs for Toxoplasmosis Segment by Application
Figure 3. Global Drugs for Toxoplasmosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drugs for Toxoplasmosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drugs for Toxoplasmosis Revenue, 2017-2028 (US$, Mn)
Figure 7. Drugs for Toxoplasmosis Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Toxoplasmosis Revenue in 2021
Figure 9. By Type - Global Drugs for Toxoplasmosis Sales Market Share, 2017-2028
Figure 10. By Type - Global Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
Figure 11. By Type - Global Drugs for Toxoplasmosis Price (USD/MT), 2017-2028
Figure 12. By Application - Global Drugs for Toxoplasmosis Sales Market Share, 2017-2028
Figure 13. By Application - Global Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
Figure 14. By Application - Global Drugs for Toxoplasmosis Price (USD/MT), 2017-2028
Figure 15. By Region - Global Drugs for Toxoplasmosis Sales Market Share, 2017-2028
Figure 16. By Region - Global Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
Figure 17. By Country - North America Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
Figure 18. By Country - North America Drugs for Toxoplasmosis Sales Market Share, 2017-2028
Figure 19. US Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Drugs for Toxoplasmosis Sales Market Share, 2017-2028
Figure 24. Germany Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 25. France Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Drugs for Toxoplasmosis Sales Market Share, 2017-2028
Figure 33. China Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 37. India Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
Figure 39. By Country - South America Drugs for Toxoplasmosis Sales Market Share, 2017-2028
Figure 40. Brazil Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Drugs for Toxoplasmosis Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Drugs for Toxoplasmosis Sales Market Share, 2017-2028
Figure 44. Turkey Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Drugs for Toxoplasmosis Revenue, (US$, Mn), 2017-2028
Figure 48. Global Drugs for Toxoplasmosis Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Drugs for Toxoplasmosis by Region, 2021 VS 2028
Figure 50. Drugs for Toxoplasmosis Industry Value Chain
Figure 51. Marketing Channels